Improvement of restless legs syndrome by varenicline as antismoking treatment

Andrea Romigi, Giuseppe Vitrani

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Varenicline is a partial agonist at the α4β2 nicotinic acetylcholine receptor effective as smoking cessation pharmacotherapy. We present a familial case of severe restless legs syndrome (RLS) resistant to polytherapy who showed a consistent and effective amelioration of RLS symptoms after introduction of varenicline as antismoking drug.

Original languageEnglish
Pages (from-to)1089-1090
Number of pages2
JournalJournal of Clinical Sleep Medicine
Volume9
Issue number10
DOIs
Publication statusPublished - 2013

Fingerprint

Restless Legs Syndrome
Nicotinic Receptors
Smoking Cessation
Drug Therapy
Therapeutics
Pharmaceutical Preparations
Varenicline

Keywords

  • Nicotinic acetylcholine receptor agonist
  • Restless legs syndrome
  • Varenicline

ASJC Scopus subject areas

  • Clinical Neurology
  • Pulmonary and Respiratory Medicine
  • Neurology

Cite this

Improvement of restless legs syndrome by varenicline as antismoking treatment. / Romigi, Andrea; Vitrani, Giuseppe.

In: Journal of Clinical Sleep Medicine, Vol. 9, No. 10, 2013, p. 1089-1090.

Research output: Contribution to journalArticle

@article{d851aad25cd54f3caaf36dd50e6d5880,
title = "Improvement of restless legs syndrome by varenicline as antismoking treatment",
abstract = "Varenicline is a partial agonist at the α4β2 nicotinic acetylcholine receptor effective as smoking cessation pharmacotherapy. We present a familial case of severe restless legs syndrome (RLS) resistant to polytherapy who showed a consistent and effective amelioration of RLS symptoms after introduction of varenicline as antismoking drug.",
keywords = "Nicotinic acetylcholine receptor agonist, Restless legs syndrome, Varenicline",
author = "Andrea Romigi and Giuseppe Vitrani",
year = "2013",
doi = "10.5664/jcsm.3092",
language = "English",
volume = "9",
pages = "1089--1090",
journal = "Journal of Clinical Sleep Medicine",
issn = "1550-9389",
publisher = "American Academy of Sleep Medicine",
number = "10",

}

TY - JOUR

T1 - Improvement of restless legs syndrome by varenicline as antismoking treatment

AU - Romigi, Andrea

AU - Vitrani, Giuseppe

PY - 2013

Y1 - 2013

N2 - Varenicline is a partial agonist at the α4β2 nicotinic acetylcholine receptor effective as smoking cessation pharmacotherapy. We present a familial case of severe restless legs syndrome (RLS) resistant to polytherapy who showed a consistent and effective amelioration of RLS symptoms after introduction of varenicline as antismoking drug.

AB - Varenicline is a partial agonist at the α4β2 nicotinic acetylcholine receptor effective as smoking cessation pharmacotherapy. We present a familial case of severe restless legs syndrome (RLS) resistant to polytherapy who showed a consistent and effective amelioration of RLS symptoms after introduction of varenicline as antismoking drug.

KW - Nicotinic acetylcholine receptor agonist

KW - Restless legs syndrome

KW - Varenicline

UR - http://www.scopus.com/inward/record.url?scp=84888170996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888170996&partnerID=8YFLogxK

U2 - 10.5664/jcsm.3092

DO - 10.5664/jcsm.3092

M3 - Article

VL - 9

SP - 1089

EP - 1090

JO - Journal of Clinical Sleep Medicine

JF - Journal of Clinical Sleep Medicine

SN - 1550-9389

IS - 10

ER -